Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2)

Patients undergoing allogeneic hematopoietic cell transplantation (HCT) are at risk for numerous acute and long-term complications from this procedure. Post-transplant diabetes mellitus (PTDM) is a common but under-recognized problem. Similar to graft-versus-host disease (GVHD), new-onset diabetes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Uttam K., Engelhardt, Brian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432328/
https://www.ncbi.nlm.nih.gov/pubmed/34595450
http://dx.doi.org/10.2991/chi.d.200506.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432328/
https://www.ncbi.nlm.nih.gov/pubmed/34595450
http://dx.doi.org/10.2991/chi.d.200506.002

Ejemplares similares